Interventional Oncology Devices Market Size Forecasted To Achieve $3.34 Billion By 2029 With Steady Growth

The Interventional Oncology Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Interventional Oncology Devices Market Size and Projected Growth Rate?
In recent years, significant growth has been witnessed in the market size of interventional oncology devices. It is forecasted to expand from $2.39 billion in 2024 to $2.52 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 5.3%. Factors contributing to this growth during the historic period include an aging population, a rise in the incidence of cancer, an upturn in pharmaceutical R&D spending, increased expenditure in healthcare, and an increase in the number of healthcare facilities.

Sturdy growth is expected in the market of interventional oncology devices in the coming years, with projection to reach $3.34 billion in 2029 and with a year after year growth rate of 7.3%. This projected surge within the forecasted period can be linked to factors such as an ageing population, an increasing choice towards less invasive surgical methods, escalating research and development investment, higher healthcare spending, promising developments in rising economies, and a growing prevalence of cancer and chronic ailments. The future trend appears to be geared towards creating advanced oncology devices with image-guidance, implementing artificial intelligence to devise innovative tools, developing fresh and novel embolic devices that can help enhance oncology processes, a focus on incorporating robotics technology, and building partnerships with other companies and research institutions to hasten product evolution and innovation.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3304

What Are the Major Segments in the Interventional Oncology Devices Market?
The interventional oncology devices market covered in this report is segmented -

1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Are The Driving Interventional Oncology Devices Market Evolution?
Major firms in the interventional oncology devices sector are concentrating on technologies like tissue volume to boost both diagnostic precision and the effectiveness of cancer treatment procedures. Tissue volume measures the quantity of biological tissue gathered in a biopsy procedure. Increasing tissue volumes contributes to a more comprehensive sample, thereby enhancing diagnostic accuracy and treatment plan effectiveness. For example, Argon Medical, a US-based medical device firm, unveiled the SuperCore Advantage semi-automatic biopsy in June 2023. The SuperCore Advantage has the potential to collect 35% more samples than its main rivals, reducing the need for repeated passes during biopsies. This capability is critical for securing sufficient tissue samples for correct diagnosis.

Which Firms Dominate The Interventional Oncology Devices Market Segments?
Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

What Trends Are Driving Growth in The Interventional Oncology Devices Market?
Leading companies are concentrating on the employment of robotics in interventional oncology devices to boost efficiency. The incorporation of the robotic system allows for precise image-based planning and navigation, coupled with adept placement of various instruments to the targeted body area. For example, the Epione interventional oncology robotics platform by Quantum Surgical was given approval by the U.S. Food and Drug Administration in March 2022.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Is The Largest Region In The Interventional Oncology Devices Market?
North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Interventional Oncology Devices Market?
2. What is the CAGR expected in the Interventional Oncology Devices Market?
3. What Are the Key Innovations Transforming the Interventional Oncology Devices Industry?
4. Which Region Is Leading the Interventional Oncology Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.